IGF 1 LR3 Capsule

IGF 1 LR3 Capsule, also known as long-chain human insulin-like growth factor capsule, is a capsule formulation product made by processing the highly active peptide substance IGF-1 LR3 modified by genetic engineering as the core raw material, combined with suitable excipients through formulation technology. This dosage form not only retains the core biological activities of IGF-1 LR3, such as promoting cell proliferation and inhibiting apoptosis, but also reduces its damage to the external environment during storage and administration through the protective effect of the capsule shell, and improves the convenience of administration. It has special value in the exploration and application of biomedical research and fitness fields, and its production, application, and control must comply with strict regulations related to biological products. As a peptide substance, it is highly sensitive to temperature, humidity, and proteases in the gastrointestinal tract. Capsule formulations have unique adaptability to it, and compared with freeze-dried powder injections, tablets, and other formulations, they have obvious advantages.

IGF 1 LR3 COA

As the largest digestive and absorptive organ and immune defense barrier in the human body, the integrity of its epithelial physical barrier directly determines the homeostasis of intestinal function. When the physical barrier of the intestinal epithelium is damaged, intestinal permeability increases, which can easily lead to dysbiosis of the intestinal microbiota, inflammatory reactions, and even systemic diseases. IGF-1 LR3 (long-chain human insulin-like growth factor-1), as a highly active peptide, can be stably released in the intestine and exert biological effects after oral administration in capsule form. In recent years, studies have shown that IGF 1 LR3 Capsule have significant protective and reparative effects on the physical barrier of intestinal epithelium, and their mechanisms involve multiple dimensions such as cell proliferation regulation and tight junction protein expression regulation.

The function of the physical barrier of intestinal epithelium can be summarized as two core functions: "selective permeability" and "defensive protection", which work together to maintain the homeostasis of the intestinal environment.

Selective permeability function

 

The balance between nutrient absorption and material barrier. Under normal circumstances, the physical barrier of the intestinal epithelium allows small molecule nutrients such as water, electrolytes, and glucose to pass through, while preventing harmful substances such as bacteria, endotoxins, and food antigens from entering the body. This selectivity mainly relies on the "pore size screening" effect of tight junctions: small molecules can be absorbed through the tightly connected "paracellular pathway" or the "transcellular pathway" of epithelial cells; However, large molecular substances are confined within the intestinal lumen due to their inability to pass through tightly connected narrow channels. In addition, surface transporters of epithelial cells, such as glucose transporter GLUT2 and amino acid transporter SGLT1, can specifically transport nutrients, further enhancing the selectivity of permeability.

Defense and protection function

 

The "first line of defense" intestinal epithelial physical barrier against external invasion resists external invasion through multiple mechanisms: first, the "physical barrier" of the mucus layer. The mucin secreted by the goblet cells forms a gel like mucus layer, which can absorb bacteria and toxins in the intestinal cavity and prevent them from directly contacting epithelial cells; The second is the "sealed defense" of tight junctions, which maintains the low permeability of the barrier and prevents the leakage of harmful substances by regulating the expression and distribution of tight junction proteins; The third is the "active clearance" of epithelial cells, which can engulf small molecules of harmful substances through phagocytosis and degrade them through lysosomes; The fourth is synergistic immune defense. When the barrier is damaged, epithelial cells can secrete cytokines (such as IL-8, TNF - α), recruit immune cells (such as neutrophils, macrophages) to clear pathogens, and repair the barrier damage.

After oral administration of IGF 1 LR3 Capsule, its absorption process requires overcoming multiple intestinal barriers, including gastric acid, intestinal proteases, and tight junctions between epithelial cells. The design of the capsule formulation provides assurance for the intestinal absorption of IGF-1 LR3:

The protective effect of capsule shell

 

IGF-1 LR3 capsules often use hydroxypropyl methylcellulose (HPMC) capsule shells, which are insoluble in the stomach (pH 1-3) and can protect IGF-1 LR3 from gastric acid damage; After reaching the intestine (pH 6-7), the capsule shell gradually dissolves and releases the active ingredient. In addition, stabilizers added to the capsule contents, such as mannitol and disodium EDTA, can prevent IGF-1 LR3 from being degraded by proteases in the intestine and maintain its biological activity.

Intestinal absorption pathway

 

As a polypeptide substance, IGF-1 LR3 is mainly absorbed in the intestine through two pathways: one is the transcellular pathway, where epithelial cells phagocytose IGF-1 LR3 into the cell to form an endosome. Before the endosome fuses with lysosomes, IGF-1 LR3 can be released to the basal side through "exocytosis" and enter the lamina propria or bloodstream; The second is the paracellular pathway, where IGF-1 LR3 can be absorbed in small amounts through the intercellular space by regulating the permeability of tight junctions. Research has shown that after oral administration of IGF-1 LR3 capsules, the local concentration of IGF-1 LR3 in the intestine is significantly higher than that in the blood, indicating that it mainly functions locally in the intestine. This characteristic makes it more suitable for the protection and repair of intestinal epithelial physical barriers.

Factors affecting absorption efficiency

 

The intestinal absorption efficiency of IGF-1 LR3 is influenced by multiple factors: firstly, the selection of excipients. Solubilizers (such as Tween 80) in the capsule contents can improve the water solubility of IGF-1 LR3 and promote its contact with epithelial cells; The second is the intestinal environment, where dysbiosis and inflammatory reactions can damage epithelial cells and affect absorption efficiency; The third is dosage. At low doses (such as 10-100 μ g/kg), the absorption efficiency is higher, and as the dosage increases, the absorption efficiency gradually saturates. Therefore, in the development of capsule formulations, it is necessary to optimize the prescription and adjust the dosage to ensure that IGF-1 LR3 reaches an effective concentration in the intestine.

The effect of IGF 1 LR3 Capsule on the integrity of the intestinal epithelial physical barrier has been validated through extensive cell experiments and animal model studies. These studies reveal the protective and reparative effects of IGF-1 LR3 from multiple dimensions such as barrier permeability, tight junction protein expression, epithelial cell proliferation and apoptosis, providing experimental evidence for its application in intestinal diseases.

Hot Tags: igf 1 lr3 capsule, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale